Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany; 2Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; 3Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy; 4Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, Kyoto, Japan and School of Public Health, Japan
Список исп. литературыСкрыть список 1. National Collaborating Centre for Mental Health. Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (Clinical Guideline CG82). London: National Collaborating Centre for Mental Health, 2009. 2. Buchanan RW, Kreyenbuhl J, Kelly DL et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010;36:71-93. 3. Bighelli I, Salanti G, Reitmeir C et al. Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials. BMJ Open 2018;8:e019280. 4. Wykes T, Steel C, Everitt B et al. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008;34:523-37. 5. Zimmermann G, Favrod J, Trieu VH et al. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schizophr Res 2005;77:1-9. 6. Jauhar S, McKenna PJ, Radua J et al. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014;204:20-9. 7. Jones C, Hacker D, Cormac I et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012;4:CD008712. 8. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med 2010;40:9-24. 9. Turner DT, van der Gaag M, Karyotaki E et al. Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. Am J Psychiatry 2014;171:523-38. 10. Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods 2012;3:80-97. 11. Hutton B, Salanti G, Caldwell DM et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015;162:777-84. 12. Shamseer L, Moher D, Clarke M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647. 13. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76. 14. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812. 15. Linden M, Schermuly-Haupt M-L. Definition, assessment and rate of psychotherapy side effects. World Psychiatry 2014;13:306-9. 16. Higgins JPT, Churchill R, Chandler J et al (eds). Cochrane handbook for systematic reviews of interventions, Version 5.2.0, Cochrane, 2017. 17. Munder T, Brütsch O, Leonhart R et al. Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clin Psychol Rev 2013;33:501-11. 18. Lieb K. von der Osten-Sacken J, Stoffers-Winterling J et al. Conflicts of interest and spin in reviews of psychological therapies: a systematic review. BMJ Open 2016;6:e010606. 19. Furukawa TA, Salanti G, Atkinson LZ et al. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. BMJ Open 2016;6:e010919. 20. Schwarzer G. meta: an R package for meta-analysis. R News 2007;7:40-5. 21. Schwarzer G, Carpenter JR, Rücker G. Meta-analysis with R (Use-R!). Basel: Springer, 2015. 22. Rücker G, Schwarzer G. Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol 2015;15:58. 23. Rhodes KM, Turner RM, Higgins JPT. Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol 2015;68:52-60. 24. Dias S, Welton NJ, Caldwell DM et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med 2010;29:932-44. 25. Higgins JPT, Jackson D, Barrett JK et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods 2012;3:98-110. 26. Chaimani A, Salanti G. Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions. Res Synth Methods 2012;3:161-76. 27. Salanti G, Del Giovane C, Chaimani A et al. Evaluating the quality of evidence from a network meta-analysis. PLoS One 2014;9:e99682. 28. Barrowclough C, Haddock G, Lobban F et al. Group cognitive-behavioural therapy for schizophrenia. Randomised controlled trial. Br J Psychiatry 2006;189:527-32. 29. Bechdolf A, Knost B, Kuntermann C et al. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr Scand 2004;110:21-8. 30. Birchwood M, Michail M, Meaden A et al. Cognitive behaviour therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomized controlled trial. Lancet Psychiatry 2014;1:23-33. 31. Drury V, Birchwood M, Cochrane R et al. Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. Br J Psychiatry 1996;169:593-601. 32. Durham RC, Guthrie M, Morton RV et al. Tayside-Fife clinical trial of cognitive-behavioural therapy for medication-resistant psychotic symptoms. Results to 3-month follow-up. Br J Psychiatry 2003;182:303-11. 33. England M. Efficacy of cognitive nursing intervention for voice hearing. Perspect Psychiatr Care 2007;43:69-76. 34. Foster C, Startup H, Potts L et al. A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions. J Behav Ther Exper Psychiatry 2010;41:45-51. 35. Freeman D, Pugh K, Dunn G et al. An early Phase II randomised controlled trial testing the effect on persecutory delusions of using CBT to reduce negative cognitions about the self: the potential benefits of enhancing self confidence. Schizophr Res 2014;160:186-92. 36. Freeman D, Dunn G, Startup H et al. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis. Lancet Psychiatry 2015;2:305-13. 37. Freeman D, Waite F, Startup H et al. Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial. Lancet Psychiatry 2015;2:975-83. 38. Garety PA, Fowler DG, Freeman D et al. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry 2008;192:412-23. 39. Gottlieb JD, Gidugu V, Maru M et al. Randomized controlled trial of an internet cognitive behavioral skills-based program for auditory hallucinations in persons with psychosis. Psychiatr Rehabil J 2017;40:283-92. 40. Habib N, Dawood S, Kingdon D et al. Preliminary evaluation of culturally adapted CBT for psychosis (CA-CBTp): findings from developing culturally-sensitive CBT project (DCCP). Behav Cogn Psychother 2015;43:200-8. 41. Haddock G, Tarrier N, Morrison AP et al. A pilot study evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early psychosis. Soc Psychiatry Psychiatr Epidemiol 1999;34:254-8. 42. Haddock G, Barrowclough C, Shaw JJ et al. Cognitive-behavioural therapy v. social activity therapy for people with psychosis and a history of violence: randomised controlled trial. Br J Psychiatry 2009;194:152-7. 43. Hazell CM, Hayward M, Cavanagh K et al. Guided self-help cognitive behavioral intervention for VoicEs (GiVE): study protocol for a pilot randomized controlled trial. Trials 2016;17:351. 44. Krakvik B, Grawe RW, Hagen R et al. Cognitive behaviour therapy for psychotic symptoms: a randomized controlled effectiveness trial. Behav Cogn Psychother 2013;41:511-24. 45. Kuipers E, Garety P, Fowler D et al. London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of the treatment phase. Br J Psychiatry 1997;171:319-27. 46. Lecomte T, Leclerc C, Corbiere M et al. Group cognitive behavior therapy or social skills training for individuals with a recent onset of psychosis? Results of a randomized controlled trial. J Nerv Ment Dis 2008;196:866-75. 47. Lee DH, Ko SM, Choi YS et al. A randomized controlled pilot study of cognitive behavioral social skills training (Korean version) for middle- or older-aged patients with schizophrenia: a pilot study. J Korean Neuropsychiatr Assoc 2012;51:192-201. 48. Lee DE, Lee HJ, Yoon OS et al. The effect of cognitive behavioral therapy in drug-resistant patients with schizophrenia. J Korean Neuropsychiatr Assoc 2013;52:26-32. 49. Levine J, Barak Y, Granek I. Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. J Cogn Psychother 1998;12:3-12. 50. Li ZJ, Guo ZH, Wang N et al. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Psychol Med 2015;45:1893-905. 51. McLeod T, Morris M, Birchwood M et al. Cognitive behavioural therapy group work with voice hearers. Part 1. Br J Nurs 2007;16:248-52. 52. Morrison AP, Turkington D, Pyle M et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014;383:1395-403. 53. Penn DL, Meyer PS, Evans E et al. A randomized controlled trial of group cognitive-behavioral therapy vs. enhanced supportive therapy for auditory hallucinations. Schizophr Res 2009;109:52-9. 54. Pinninti NR, Rissmiller DJ, Steer RA. Cognitive-behavioral therapy as an adjunct to second-generation antipsychotics in the treatment of schizophrenia. Psychiatr Serv 2010;61:940-3. 55. Pot-Kolder RMCA, Geraets CNW, Veling W et al. Virtual-reality- based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial. Lancet Psychiatry 2018;5:217-26. 56. Rector NA, Seeman MV, Segal ZV. Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophr Res 2003;63:1-11. 57. Sensky T, Turkington D, Kingdon D et al. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Arch Gen Psychiatry 2000;57:165-72. 58. Startup M, Jackson MC, Bendix S. North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months. Psychol Med 2004;34:413-22. 59. Tarrier N, Yusupoff L, Kinney C et al. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. BMJ 1998;317:303-7. 60. Trower P, Birchwood M, Meaden A et al. Cognitive therapy for command hallucinations: randomised controlled trial. Br J Psychiatry 2004;184:312-20. 61. Turkington D, Kingdon D. Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. Br J Psychiatry 2000;177:101-6. 62. Valmaggia LR, van der Gaag M, Tarrier N et al. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. Br J Psychiatry 2005;186:324-30. 63. van der Gaag M, Stant AD, Wolters KJ et al. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. Br J Psychiatry 2011;198:59-65. 64. Velligan DI, Tai S, Roberts DL et al. A randomized controlled trial comparing cognitive behavior therapy, cognitive adaptation training, their combination and treatment as usual in chronic schizophrenia. Schizophr Bull 2015;41:597-603. 65. Wahass S, Kent G. The modification of psychological interventions for persistent auditory hallucinations to an Islamic culture. Behav Cogn Psychother 1997;25:351. 66. Wittorf A, Jakobi UE, Bannert KK et al. Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance? J Nerv Ment Dis 2010;198:478-85. 67. Wykes T, Hayward P, Thomas N et al. What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophr Res 2005;77:201-10. 68. ACTRN12616000976482. Efficacy of individualised metacognitive therapy (MCT+) for delusions in psychosis. Australian New Zealand Clinical Trial Registry, 2016. 69. Briki M, Monnin J, Haffen E et al. Metacognitive training for schizophrenia: a multicentre randomised controlled trial. Schizophr Res 2014;157:99-106. 70. Favrod J, Rexhaj S, Bardy S et al. Sustained antipsychotic effect of metacognitive training in psychosis: a randomized-controlled study. Eur Psychiatry 2014;29:275-81. 71. Kumar D, Zia Ul Haq M, Dubey I et al. Effect of meta-cognitive training in the reduction of positive symptoms in schizophrenia. Eur J Psychother Couns 2010;12:149-58. 72. So SH, Chan AP, Chong CS et al. Metacognitive training for delusions (MCTd): effectiveness on data-gathering and belief flexibility in a Chinese sample. Front Psychol 2015;6:730. 73. van Oosterhout B, Krabbendam L, de Boer K et al. Metacognitive group training for schizophrenia spectrum patients with delusions: a randomized controlled trial. Psychol Med 2014;44:3025-35. 74. Chadwick P, Hughes S, Russell D et al. Mindfulness groups for distressing voices and paranoia: a replication and randomized feasibility trial. Behav Cogn Psychother 2009;37:403-12. 75. Chadwick P, Strauss C, Jones AM et al. Group mindfulness-based intervention for distressing voices: a pragmatic randomised controlled trial. Schizophr Res 2016;175:168-73. 76. Bach P, Hayes SC. The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. J Consult Clin Psychol 2002;70:1129-39. 77. Shawyer F, Farhall J, Thomas N et al. Acceptance and commitment therapy for psychosis: randomised controlled trial. Br J Psychiatry 2016;210:140-8. 78. Schnackenberg J, Fleming M, Martin CR. A randomised controlled pilot study of Experience Focused Counselling with voice hearers. Psychosis 2017;9:12-24. 79. Jenner JA, Nienhuis FJ, Wiersma D et al. Hallucination focused integrative treatment: a randomized controlled trial. Schizophr Bull 2004;30:133-45. 80. Craig TK, Rus-Calafell M, Ward T et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: a single-blind, randomised controlled trial. Lancet Psychiatry 2018;5:31-40. 81. Adams CE, Coutinho E, Davis JM et al. Cochrane Schizophrenia Group. The Cochrane library. Chichester: Wiley, 2011. 82. Leucht S, Kane JM, Kissling W et al. What does the PANSS mean? Schizophr Res 2005;79:231-8. 83. Hutton P. Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: a commentary on a commentary. Schizophr Res (in press).